Future Pharma 2018

September 26 - 28, 2018

The Westin Copley Place, Boston, MA

Contact Us: 1.888.482.6012


Dave Moore
Senior Vice President, Commercial
Novo Nordisk
Mike Exton
Vice President & Head, Cardiovascular Franchise
Ana Cespedes Ph.D., MBA
Senior Vice President, Global Marketing and Strategy
EMD Serono, a business of Merck KGaA
Bharti Rai
Chief Commercial Data Officer
Wendy Kouba
Vice President, Brand & Communications
Teva Pharmaceuticals
Najur Runganadhan
COPD Commercial Effectiveness Head

Najur Runganadhan is a Business Partner, supporting the US Pharma Division at Novartis.  He was previously Head of Commercial Effectiveness for the US Pharma COPD Franchise, and joined Novartis as a lead within the Portfolio & Advanced Analytics team, supporting the US Pharma Division.

Prior to Novartis, Najur led the West Coast CES Delivery Team at IMS Health, supporting a broad variety of pharma, bio-tech and oncology focused companies, primarily located on the West Coast.

He also has extensive experience working at the brand and portfolio level across Patient and HCP focused sales, marketing and commercialization efforts in both client-side and consulting roles, for companies such as J&J, Pfizer, Wyeth, AstraZeneca, Lily, and others.

He has led and been part of pre-launch, launch and LOE product teams, working across a variety of therapeutic areas within the CV, Metabolics, Oncology, Immunology, Neuroscience, GI, Infectious Disease and Vaccines categories.

Bryan Cohen
North America Digital Platform Lead, Promotional Operations
Grant Huang
Director, Established Product Portfolio Marketing
Otsuka Pharmaceutical
John Sears
Director, Value-Based Care Commercial Strategy
Greg Palko
Head, US Oncology
Sun Pharmaceuticals
Eric Rothstein
Executive Director, Remote Engagement
John Alter
Vice President, Global Health & Value, Global Established Pharma Business Unit
John is currently Vice President, Global Health and Value for Pfizer’s Essential Health business unit, which has worldwide sales of more than $20B from a portfolio of over 700 molecules including biosimilars, sterile injectables and solid oral dosage forms. The portfolio is the result of Pfizer’s research and development as well as from the acquisitions of Warner Lambert, Pharmacia and Upjohn, Wyeth and most recently Hospira. Pfizer is the world’s leading biosimilars company based on audited sales and its portfolio of biosimilar molecules is for the treatment of inflammation, oncology and supportive care.

Pfizer’s Global Health and Value team covers the functions of Pricing, Access, Reimbursement, Health Economics, Outcomes Research and Real World Data. John has been with Pfizer for over 18 years in multiple roles of increasing responsibilities, the last three years in his current role. He has presented at several biosimilars conferences on the topic of pricing and access and in 2016 was a guest lecturer on the subject of HEOR at Kings College London as part of the International Federation of Association of Pharmaceutical Physicians.
Meg Heim
Vice President & Head, Diabetes and CV Scientific Communications - North America
Erica Voll
Associate Director, Content Strategy, Customer Experience & Innovation
Keith Willis
Associate Director, Cardiovascular, Sales Training
Bristol-Myers Squibb

Keith has 25 years of experience in the pharmaceutical industry where he honed his sales, sales management, operations and sales training skills with top fortune 500 companies. Keith is currently an Associate Director at Bristol-Myers Squibb were he leads a training team.

Frank Washenitz
Head of Global / NA Sales Training
Joseph Williams
Associate Director, Sales Training
Amy West
Senior Director, Patient Marketing & Digital Health Innovation
Novo Nordisk
J.D. Lineen
Global Channel Lead, Web & Mobile, Global Commercial Strategy & Platforms
Mark Pizzini
Digital Strategy Lead, Business Unit

Mark has over 20 years of experience partnering with Executives to make technology investments that drive business results.  Mark is currently Business Technology Lead for Cardiovascular Metabolic at Pfizer. He has been leading the Global Innovative Pharma Digital Program for the last 2 years to target investments in emerging areas of digital healthcare. He also co-leads Quitter’s Circle, an innovative digital program to get smokers to engage in HCP assisted quits. During his 18 years at Pfizer, Mark has held several leadership roles in Business Technology, helping executives exploit marketplace opportunities using technology and process including: Commercial Operations, Specialty & Oncology, Drug Portfolio Management, Primary Care U.S. and Pfizer Health Solutions.

Prior to his career at Pfizer, Mark was an Engagement Leader with Arthur Andersen Business Consulting for 8 years. During this time he led many large-scale business transformation programs for such companies as NYNEX, GTE, Columbia Gas and Weyerhaeuser Mortgage. Mark was a key player in developing the Arthur Andersen's Business Consulting practice in both the Los Angeles and New York. 

Carol Perriccio
Manager, Sales Training

Don DeStefano
Vice President, Business Development

Don is the Vice President of Business Development, and is responsible for the overall performance of the LexisNexis claims-based solutions.

Don has over 20 years of experience in the health care industry, spanning roles in market research, sales, and account management. At LexisNexis, Don has responsibilities for business development and account management. He works with pharmaceutical, biotech, and medical device companies, as well as other health care-related organizations, to provide strategic consulting and information solutions to sales, commercial operations, and marketing, across the full range of LexisNexis Market Intelligence solutions.

Prior to joining LexisNexis, Don was Sales Director at IMS Health, one of the world’s largest data and information companies in the pharmaceutical and healthcare industry. In this role, he supported numerous clients across multiple segments, including pharmaceutical and biotech companies, ad agencies, government agencies, consulting firms, and other health care-related organizations.

Don holds a BS in Business from Stockton University, and an MBA in Pharmaceutical Marketing from St. Joseph’s University.

Jason Morhart
Marketing Director
Jason Morhart is the Marketing Director at Astellas Pharma Inc. leading the healthcare professional channel marketing efforts. He has over 18 years of pharmaceutical industry experience, including various roles in sales and marketing at Bristol-Myers Squibb, Hospira, and Accera Inc., before joining Astellas in 2012. His experience in Dermatology, Neuroscience, HIV/AIDS, Critical Care, Oncology and Urology is in a variety of traditional pharma and start-up environments. He also serves as a Lieutenant Colonel in the United States Army Reserve with over 23 years combined active and reserve duty. Jason received his Bachelor of Arts degree in Biology from University of Colorado, Boulder and Master of Business Administration degree from Notre Dame.
Frank Armenante
Director, Sales Execution
Novo Nordisk
Tom Mccourt
Chief Commercial Officer
Ironwood Pharmaceuticals
Mike Moran
Vice President & Head of Sales, US
Eagle Pharmaceuticals
Brad Hummel
Oncology Sales Trainer
Bristol-Myers Squibb

Brad Hummel has more than 16 years of commercial experience in the Life Sciences industry. He has served in various sales, training, and management roles to support pharmaceuticals, medical devices, and specialty pharmacy services. Currently, Brad is responsible for developing and delivering training content to support the Lung Cancer sales force at Bristol-Myers Squibb. Before joining BMS, he was the Director of Field Force Effectiveness and Sales Training at Entera Health. Brad is an expert in the psychology of influence with a proven track record of success implementing advanced sales methodologies. He is also an authority in sales simulation and how to build programs that truly drive sales performance.

Bob Rossilli
Vice President, Sales
Bio Products Laboratory

With over 25 years of experience in the pharmaceutical industry Bob has continually demonstrated a passion for building customer focused teams, strong employee engagement and delivering results. He has worked closely with a variety of key stakeholders within the industry to ensure patient-centric solutions help improve outcomes in local communities across the US. In his current role, Bob is the head of sales for Bio Products Laboratory leading his sales team across all classes of trade.

Previously Bob has led large pharma sales teams as a Vice President with national responsibility for GSK and Sanofi in specialty, hospitals, primary care, LTC and IDNs in the respiratory, cardiovascular, metabolic, urology and diabetes therapeutic areas.

Sandra Sexton
Director, Consumer Marketing
Regeneron Pharmaceuticals
Steve Winawer
IT Lead, North America
Jay Sabbah
Senior Director, Marketing - Zoster

Adam Shandler
Director, Talent Acquisition & Talent Development
Dr. Reddy’s Laboratories

Adam is the Director of Human Resources and Learning & Development at Dr. Reddy’s Laboratories, a global pharmaceutical firm with North American headquarters in Princeton, NJ. He believes a company’s winning pathways run through the talent it hires and develops, and he’s dedicated his near-20-year career to ensuring talent is of the utmost focus. Adam has also held Talent Acquisition and Talent Development leadership positions with Medco Health Solutions, Stryker, and Sanofi. Among his “career trophies”, Adam launched Medco’s first MBA leadership program as well as Stryker Spine’s first learning programs benefitting all employees. His Management Development Program for emerging leaders at Dr. Reddy’s won the 2016 Chief Learning Officer Bronze Talent Management Award. Adam has delivered training on three continents thus far. His goal is to teach on all seven continents. (Yes, even Antarctica!)

Currently, Adam is partnering with John Riggle, Sales Training Director at Dr. Reddy’s branded business, Promius, to roll out a new Field Leaders program for high performing members of its sales force.

Paul Murasko
Senior Director, Multichannel Marketing
Sunovian Pharmaceuticals
Brian Peters
Vice President, Marketing
Medac Pharma

Brian Peters is Vice President, Marketing, for Medac Pharma, Inc, where he recently led the launch efforts for Medac Pharma’s first product. He brings 28 years of both client and agency side strategic pharmaceutical marketing experience to the Brand & Portfolio Management for Specialty Products event. Working in a small company environment, he wears many hats and brings a unique perspective on the challenges of pharma marketing with limited resources.

Bob Holliday
Senior Director, Learning & Development
PTC Therapeutics
Bob Holliday is the Senior Director of General Medicines Training at Sanofi Pharmaceuticals. He has over 25 years of training experience with 15 in the pharma/biotech  industry. In that time he as lead the launch training of over 25 product launches both in the US and globally. He currently leads a team of 34 dedicated to developing a comprehensive curriculum for the General Medicines business of over 3000 sales professionals and leaders. The team has already launched 3 new products this year and has 4 more in development.
Bryan Selby
Vice President, Sales & Marketing
Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals
Larry Bressler
Vice President, Global Launch Lead - Rare Disease
Rhythm Pharmaceuticals
Jill Donahue
The Aurora Project

Jill Donahue, HBa, MAdEd is on a mission to lift pharma – to help us gain back our ability to influence and contribute to better outcomes.

When Jill was 35, she lost her father to an avoidable prescribing error. As a professional in the pharmaceutical industry, she asked herself: ‘What if my Dad’s doctor’s rep had been able to access and influence him more effectively?’

She is a firm believer that the greatest outcomes will be achieved when we shift from being script centric to patient centric. As a global thought leader in pharma, she is winning awards for her work, delivering talks at global conferences, publishing in industry journals and serving pharma teams.

To help commercial pharma people influence ethically so they can make a difference in patient outcomes and improve sales simultaneously, she authored 2 books which became the most popular programs ever seen at Canada’s Council for Continuing Pharmaceutical Education. These spread by word of mouth to 25% of the reps in Canada and won the LTEN Award of Excellence. She also co-founded The Aurora Project; a global volunteer group of thought leaders trying to illuminate commercial pharma’s path to patient centricity.

Jill’s programs are engaging, insightful and game-changing. You can connect with her at https://www.linkedin.com/in/jillexcellerate/

Ahmed Elemam
Director, Digital Marketing & Analytics
Kiki Anku
Co-Founder & Chief Executive Officer
Filip Witkowski

Dr. Geissler is an expert in applied behavior analysis with a focus on organizational behavior management.  Organizations engage her to help with change planning and implementation, performance improvement, leadership team alignment and development, and executive coaching.  Industries she has supported in Europe, North America and the Far East include biotech, manufacturing, health insurance, consumer goods, banking, and others. 

From 2014 through 2017, she was an invited professor in the Executive MBA Program at the Business School at Keio University, Tokyo, Japan. Her courses focused on the role of behavioral leadership in small- and large-scale global change efforts. 

Dr. Geissler co-authored a chapter in The Behavior Breakthrough (2013), detailing Behavioral Leadership to enable superior execution and regularly speaks at conferences globally.  

Jonathan Lanznar
Director, Life Sciences
Neil Keene
Digital Pharma

Antoun Nabhan
Vice President, Corporate Development
Pear Therapeutics
Patty Nece
National Board
Obesity Action Coalition
Dr. Donney John
Chief Clinical Officer
Pharmacist Partners
Dr. John is leading our Hospital Transition in Care and our Employer Solutions programs. He is a practicing pharmacist, healthcare consultant, entrepreneur and patient advocate.  Dr. John has considerable expertise in the areas of patient engagement, population health management, transition in care and mobile health technology solutions. He serves as a medical advisor for a variety of companies focused on health/wellness, patient engagement and medication adherence.

Dr. John is also the Executive Director of NOVA Scripts Central a non-profit pharmacy that provides medications to uninsured patients in the Northern Virginia area. He is the founder of Urban Medical Solutions, which is focused on raising awareness of health literacy with in the underserved patient population.   Dr. John has previously worked in academia serving as an Assistant Professor of Pharmacy Practice at Massachusetts College of Pharmacy & Health Sciences where he developed innovative ambulatory care practice sites within federally qualified community health centers.  He has worked to train healthcare professionals in the areas of health literacy and cultural competency in order to address health dispartities.

Dr. John holds a Doctor of Pharmacy degree from St. John’s University in Queens, New York and has completed a pharmacy residency with Massachusetts College of Pharmacy & Health Sciences.
Charleen Ring
Program Director
Future Pharma
Charleen is an experienced content director, market researcher and published author with a passion for creative storytelling. She produces innovative b2b networking conferences that serve as platforms to help businesses and professionals create narratives that inspire and foster connectivity between industry thought leaders. Her portfolio currently focuses on events in the life sciences and travel, hospitality and leisure industries. She manages WBR’s Digital Travel Summit, Future Pharma (Formerly PharmaForce), MedForce, and NGPX. When not developing awesome programs, you can find her working on her next novel, traveling with her husband, or Instagramming photos of her beloved French Bulldog, Marv.
Fernando Schwartz
Chief Data Scientist

Fernando has over 20 years experience in quantitative research, and almost a decade focused on building high-performing, cross-functional teams that find innovative solutions to challenging problems in big data. Fernando is a skilled mathematician and a thought leader when it comes to monetizing massive transactional datasets. Prior to joining Prognos, Fernando was Chief Data Scientist at LiveIntent, where he founded the Data Science and Analytics group. Fernando invented and deployed a market forecasting tool that generated a multi-million dollar lift in monthly booked revenue, leveraging AI and optimization algorithms. Prior to LiveIntent, Fernando worked in data science at AppNexus, where he designed a budgeting algorithm in charge of allocating over $200M of annual revenue through 5B+ daily transactions.

Fernando received both his BS in Engineering and Mathematical Engineering degrees from the University of Chile, and obtained his PhD in Mathematics from Cornell University. He held postdoctoral positions at Duke University and the University of Warwick (UK). Fernando has dozens of peer-reviewed scientific publications in mathematics and its applications to data science, including computational geometry and topological data analysis. Fernando became a tenured faculty member of the Mathematics Department at the University of Tennessee, where he currently holds an honorary Adjunct Professorship.

Jude Konzelmann
ZS Associates

We're always looking ahead to book a roster of inspiring speakers. Contact us today to reserve your spot.

Want to see who spoke previously? Check out the link below.

View 2017 Speakers